Welcome to Greenshoots

Greenshoots is a collection of fresh intellectual property insight, analysis and commentary on the issues that matter most to those who invent, manage and protect intellectual property, written by the IP specialists of Appleyard Lees.

Now that you’re here, why not take a look around?

Articles

UK SEP/FRAND interim licence declarations – an exercise of the Court’s jurisdiction or of ‘judicial imperialism’?

Last week, the High Court issued its judgment on interim FRAND licences in Samsung v ZTE.

Read more
Webinars

KE Matters – How to protect your AI inventions

Discover what it takes to secure protection for AI-driven technologies through real-world scenarios—including autonomy stacks in self-driving vehicles and a computer vision system.

Read more
Articles

G1/24 Decision of the Enlarged Board of Appeal

The Enlarged Board of Appeal issued their decision in the case of G1/24 on 18 June 2025. Our experts discuss the relevance for IP professionals.

Read more
Articles

When can legitimate goods be modified and resold using the original trade mark?

This article examines the legal principles of trade mark exhaustion and explores how brand owners can manage their reputation after goods have been sold.

Read more
Articles

The power of organoids – advances in disease modelling research

In March 2025, the first Cambridge Human Organoid Symposium took place at Jesus College, Cambridge. Having attended, trainee patent attorney Oliver Herd shares the latest research findings presented. 

Read more
Articles

Targeting the undruggable proteome with molecular glues

Recent patent and clinical trial activity highlights a rising global interest in molecular glue research to improve patient outcomes for cancer, neurodegenerative, and autoimmune disease treatments.

Read more
Articles

Patent filings in treatments for neurodegenerative disorders: a shift toward biotherapeutic innovation

This article explores a major shift in global patent filings for neurodegenerative disorder therapies over the past decade. Once dominated by big pharma’s small molecules, innovation is now increasingly led by SMEs developing biotherapeutics targeting root causes. This trend reflects rising interest in precision medicine and suggests progress toward more effective treatments beyond symptom management.

Read more
Podcasts

The Greenshoots Podcast by Appleyard Lees – Inside Green Innovation: Progress Report – Nuclear

In this episode, join Partner and Patent Attorney, Adam Tindall along with Senior Associate and Patent Attorney, Matthew Bennett, as they discuss the current state of IP in the nuclear industry, interesting technology insights, and fusion and fission IP, as featured in their article as part of the Inside Green Innovation: Progress Report.

Read more
Articles

Optus v Apple – CoA increases FRAND licence to $500m ($700m with interest) in favour of Optus

In a judgment that further swings the pendulum back towards the UK being a 'SEP-owner-friendly' jurisdiction, the CoA has set the terms of the FRAND licence payable by Apple at a little over $700m ($500m + $200m interest).

Read more
Articles

IP audits – what are the benefits?

In this article, Senior Associate, Rachel Mercer, and Trainee Patent Attorney, Emma Lyons, explore the value of IP audits for businesses of all sizes. Discover how an audit can uncover hidden assets, support funding efforts, and strengthen your IP strategy. With the UKIPO’s updated ‘IP Advance’ scheme offering financial support to SMEs, now is an ideal time to assess and optimise your IP portfolio.

Read more
Articles

Patenting user-centric inventions in the UK is technically possible

In this article, we look at a recent UK case that illustrates how a user-centric invention that utilises hardware components, such as sensors and displays, can still fail to have an effect on a technical process. We also discuss how we can help you to determine whether a user-centric invention is likely to be patentable or not patentable in the UK.

Read more
1 4 5 6 7 8 39
Skip to content